Financials
Interim Results | Sep. 23, 2024 |
Half Year Trading Update and Notice of Results | Aug. 08, 2024 |
2023 Annual Report and Accounts | Apr. 30, 2024 |
Prelim Results for Y/E 2023 - REPLACEMENT | Apr. 29, 2024 |
Preliminary results for the year ended 31 Dec 2023 | Apr. 29, 2024 |
2022 Annual Report and Accounts | Apr. 28, 2023 |
Preliminary results for the year ended 31 Dec 2022 | Apr. 25, 2023 |
Proxies
2024 Annual General Meeting Notification | May. 15, 2024 |
2024 Notice of Annual General Meeting | May. 15, 2024 |
Result of AGM | Jun. 23, 2023 |
2023 AGM minutes and resolutions | Jun. 23, 2023 |
2023 AGM Notification | May. 05, 2023 |
Notice of 2023 AGM | May. 05, 2023 |
Result of AGM | May. 27, 2022 |
Ownership Update
Grant of options | Nov. 22, 2024 |
Grant of options | Nov. 05, 2024 |
Holding(s) in Company | Nov. 04, 2024 |
Holding(s) in Company | Oct. 31, 2024 |
Grant of Options | Oct. 04, 2024 |
Holding(s) in Company | Oct. 03, 2024 |
Holding(s) in Company | Oct. 01, 2024 |
Announcements
Total Voting Rights | Dec. 02, 2024 |
Board Changes | Nov. 18, 2024 |
OXB to present at Jefferies Healthcare Conference | Nov. 15, 2024 |
Total Voting Rights | Nov. 01, 2024 |
Block Listing Application | Oct. 21, 2024 |
Total Voting Rights | Oct. 01, 2024 |
Oxford Biomedica rebrands as OXB | Sep. 18, 2024 |
Prospectuses
prosectus | Sep. 13, 2016 |
Prospectus | May. 29, 2014 |
Firm Placing and Placing and Open Offer | Dec. 13, 2010 |